Adial Pharmaceuticals, Inc. Fair Value Adjustment of Warrants
Adial Pharmaceuticals, Inc. (ADIL) reported Fair Value Adjustment of Warrants of -$8.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- Adial Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$8.28M.
- Adial Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month |
|---|---|---|---|
| 2026-06-30 | -$8.28M 10-Q · filed 2026-08-14 | -$8.28M 10-Q · filed 2026-08-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.69K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$1.69K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |